The AAA-ATPase VCP (also known as p97 or CDC48) uses ATP hydrolysis to 'segregate' ubiquitylated proteins from their binding partners. VCP acts through UBX-domain-containing adaptors that provide target specificity, but the targets and functions of UBXD proteins remain poorly understood. Through systematic proteomic analysis of UBXD proteins in human cells, we reveal a network of over 195 interacting proteins, implicating VCP in diverse cellular pathways. We have explored one such complex between an unstudied adaptor UBXN10 and the intraflagellar transport B (IFT-B) complex, which regulates anterograde transport into cilia. UBXN10 localizes to cilia in a VCP-dependent manner and both VCP and UBXN10 are required for ciliogenesis. Pharmacological inhibition of VCP destabilized the IFT-B complex and increased trafficking rates. Depletion of UBXN10 in zebrafish embryos causes defects in left-right asymmetry, which depends on functional cilia. This study provides a resource for exploring the landscape of UBXD proteins in biology and identifies an unexpected requirement for VCP-UBXN10 in ciliogenesis.
1
. VCP functions in diverse processes such as endoplasmic reticulum (ER)-associated degradation (ERAD), macro and selective autophagy and DNA damage responses 2, 3 (DDRs). ATP hydrolysis by VCP remodels protein complexes, unfolds ubiquitylated substrates for degradation, and extracts proteins embedded in membranes or chromatin. The prevailing model suggests that specific adaptor proteins target VCP to cellular structures and substrates where VCP activity is required 3 . The largest family of adaptors contains the ubiquitin X domain (UBXD), which adopts a ubiquitin fold and associates with the amino terminus of VCP (Fig. 1a ) 4 . A subset of UBXD proteins also contain ubiquitin-associated domains (UBA), to recognize polyubiquitin chains on substrates 5 . Other cofactors utilize shorter motifs to associate with VCP (ref. 6 ). Some studies have suggested the involvement of distinct adaptors in specific processes; however, UFD1L-NPLOC4 association with VCP is required in some cases for adaptor binding 7 .
Our understanding of how VCP is targeted to substrates is limited and only a subset of adaptors have been studied in detail. Even for adaptors such as UBXN7 whose role in cullin RING ligase (CRL) function has been reported, the full repertoire of targets and biological pathways remain unknown. VCP is mutated in human neurodegenerative disorders including inclusion body myopathy, Paget's disease of the bone and frontotemporal dementia and amyotrophic lateral sclerosis 8, 9 . A significant fraction of disease-specific mutations cluster to the N terminus where adaptors bind, suggesting that alterations in the repertoire of adaptors associated with VCP could contribute to disease 10, 11 . Thus, a more complete understanding of adaptors and their targets is needed to fully understand VCP function.
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(BBSome) complex-dependent manner. Although hundreds of candidate ciliary proteins have been identified, their functions remain largely uncharacterized [18] [19] [20] . Through biochemical studies coupled with genetic and pharmacological disruption of VCP-UBXN10 function, we reveal a role for this complex in promoting ciliogenesis in mammalian cells in culture and in zebrafish. The VCP-UBXD network elaborated here provides a resource for further elucidation of the targeting mechanisms and biological functions of VCP.
RESULTS

Mapping the VCP-UBXD adaptor protein network
We used an unbiased comparative proteomic approach to develop a physical map of the VCP-UBXD network in 293T cells stably expressing one of thirteen FLAG-HA-UBXD proteins, UFD1L, NPLOC4 or VCP through lentiviral transduction (Fig. 1a,b) . As UBX adaptors have protein interaction domains near their amino and carboxy termini (Fig. 1a) , we created both N-and C-terminally tagged proteins, with the exception of N-tagged UBXN11 and ASPSCR1, which failed to generate stable cell lines (Supplementary Table 1) . Immunoblotting with available antibodies demonstrated expression levels of the tagged protein ranging from 0.6-4.5-fold compared with the endogenous protein ( Supplementary Fig. 1a ). We also created HeLa cells expressing N-or C-terminally tagged VCP or its adaptors and determined their sub-cellular localization (Fig. 1b,c and Supplementary Fig. 2 ), allowing correlation with the known localization of interaction partners. These 30 cell lines were subjected to two independent anti-FLAG magnetic bead affinity purification-mass spectrometry (AP-MS) experiments and one anti-HA agarose AP-MS experiment ( Fig. 1b and Supplementary  Fig. 1b) . To filter the >400 proteins identified for each bait for high-confidence interacting proteins (HCIPs), we employed the Comparative Proteomics Analysis Software Suite (CompPASS) platform, which uses a database containing AP-MS-derived APSM (assembled peptide spectral match) data for >100 unrelated bait proteins to identify nonspecific contaminants. CompPASS determines HCIPs on the basis of a normalized weighted D score (NWD score) measuring the frequency with which interactors appear in the database, the abundance (APSM-based), and the reproducibility of detection in technical replicates 12, 13, 21 . An APSM-based Z-score was also employed for identifying proteins that are often seen in AP-MS experiments but are selectively enriched with particular baits 12, 13, 21 . We designated interactors as HCIPs if they passed three criteria: NWD ≥ 0.98; Z ≥ 4; and APSM ≥ 2. Proteins scoring below this threshold may still represent bona fide interactors, but could be weakly associated or sub-stoichiometric. In most cases, bait abundance and the overall number of HCIPs were similar between N-and Cterminally tagged proteins ( Supplementary Fig. 1b ).
Overview and topology of the VCP-adaptor network
We organized HCIPs into tiers based on their reproducible identification in both anti-FLAG and anti-HA data sets ( Fig. 1d and Supplementary Fig. 1d ). Overall, we identified 169 HCIPs (54 unique proteins) from both N-and C-terminal baits for either anti-FLAG-or anti-HA-purified complexes, which we designate as Tier 1 HCIPs (Fig. 1d and Supplementary Fig. 1c and Supplementary Table 2 ). We identified 149 HCIPs (125 unique proteins) in replicate analyses in either N-or C-terminally tagged baits from the anti-FLAG data set, which we refer to as Tier 2 ( Fig. 1d and Supplementary Fig. 1c and Supplementary  Table 2 ). Finally, 680 interactions (481 unique proteins) were found only once across all baits (Tier 3); these HCIPs are of lower confidence than Tier 1 and 2 HCIPs ( Supplementary Fig. 1c and Supplementary Table 2 ). Most Tier 1 and 2 HCIPs had adjusted P values ≤ 0.05 based on a hypergeometric test that evaluated the likelihood of non-random association among bait and prey observations across all liquid chromatography-mass spectrometry analyses in each data set (Supplementary Table 4) . As described below, we observed extensive validation for selected HCIPs using reciprocal interaction approaches.
Hierarchical clustering revealed that although most HCIPs were unique to individual UBXD proteins, a subset were found in common between baits; for example, UBXN2A and UBXN2B associated with a phosphatase complex (Fig. 1e) . A number of HCIPs were common to many UBXD proteins, including the known VCP-associated deubiquitylating enzyme VCPIP, the BAG6 complex (UBXN1, FAF2), and CUL3 adaptors TNFAIP1, KCTD10, KCTD13 (UBXN1, FAF1, UBXN7). It was evident that some interactions are dependent on the position of the epitope tag; UBXN1-HA-FLAG associated with the BAG6 complex but HA-FLAG-UBXN1 did not (Fig. 1e) .
Of the 89 interactions reported in BioGRID in high-throughput AP-MS experiments with the adaptors analysed here, 23 were identified as Tier 1 and 2 HCIPs (Fig. 2a and Supplementary  Table 3 ). Of 69 interactions identified by immunoprecipitationimmunoblotting (IP-IB), 17 were present in Tier 1 and 2 and finally for yeast two-hybrid data, 4 of 56 reported interactions were identified in Tier 1 and 2 (Fig. 2a) . A number of BioGRID interactions were also identified in our data set but did not pass our stringent filtering criteria (65 interactions in AP-MS, 38 interactions in IP-IB and 17 interactions in yeast two hybrid; Fig. 2a) . Furthermore, 29 of 39 interactions reported in a previous study examining 5 UBA-UBXD adaptors by AP-MS (ref. 5) were identified in our study (9 in Tier 1 and 2 and 20 below our filtering criteria, Fig. 2b ). Moreover, our study identified 83 Tier 1, 106 Tier 2 that are not reported in BioGRID, and thereby represents the largest collection of candidate UBXDinteracting proteins reported so far.
Placement of UBXD proteins within cellular modules
We identified interactions among UBXD proteins that were not previously reported, thereby extending potential crosstalk between UBXD proteins possibly assembled on the same VCP hexamer. Of the 14 UBXD proteins in BioGRID, 8 have been reported to interact with UFD1L and/or NPLOC4. In addition, UBXN6 has been reported to associate with FAF2 and ASPSCR1, and NSFL1C has been reported to interact with UBXN11 (Fig. 2c) . In our data set, UFD1L and/or NPLOC4 associated with 11 of 14 UBXD proteins (Fig. 2c ). UBXN2A and UBXN6 associated with 6 and 5 distinct UBXD proteins, respectively (Fig. 2c) . ASPSCR1 has been proposed to function in the assembly of the VCP hexamer 22 and associated with 6 UBXD proteins (Fig. 2c) . Although we cannot rule out the possibility that the interactions we observe may represent adaptor exchange postlysis, it suggests that VCP-adaptor modules may be more complex than appreciated at present.
We organized the VCP-adaptor network globally and individually, focusing on Tier 1 and 2 HCIPs (Figs 2d and 3a-g 
Sub-threshold
Not identified
Overlap between UBA-UBX interactors identified in this study (Tiers 1, 2) and ref. 5   FAF1   UBXN11   UBXN2B   UBXN2A   UBXN6   ASPSCR1   FAF2   NSFL1C   UBXN10   UBXN4   UBXN8   UFD1L   NPLOC4   UBXN7   UBXN1 VCP UBXN10  UBXN2A  UBXN7  FAF2  UBXN1  FAF1  ASPSCR1  UBXN8  UFD1L  NPLOC4  UBXN4  UBXN6  UBXN2B and Supplementary Fig. 3 and Supplementary Table 2 ). Gene Ontology analysis of Tier 1 and 2 HCIPs shows enrichment for numerous biological processes, including ubiquitin signalling, protein trafficking, membrane transport, DDR and metabolism ( Fig. 2d and Supplementary Fig. 1d ). HCIPs frequently localize in the same compartment as the bait. For example, nuclear UBXN7 (Fig. 1c) associated with transcription-coupled nucleotide repair machinery, other DDR proteins, and CRL components (Figs 2d and 3b) 6, 23 . VCP-UBXN2B mediates homotypic membrane fusion and promotes ER and Golgi biogenesis during interphase [24] [25] [26] . Phosphorylation of UBXN2B has been proposed to regulate this process 27 ; however, the in vivo kinase is unknown at present. We identified two kinases-GSK3β and CDC42BPB-in association with UBXN2B (Fig. 3e) .
Several UBXD-associated proteins associate with membrane components. We found that the membrane-tethered FAF2 (also called UBXD8) that functions in ERAD and lipid droplet homeostasis 21, 28 associated with AMFR, DERLIN2, AUP1, BAG6 and UBAC2 (Figs 2d and 3c) as expected. We unexpectedly observed partial co-localization of FAF2 with mitochondria ( Fig. 1c and Supplementary Fig. 1e ) and observe several mitochondrial proteins in association with FAF2, although we cannot rule out post-lysis association (Fig. 3c) . Further studies are required to determine whether FAF2 has a role in mitochondrial function. UBXN8, also implicated in ERAD (ref. 29) , shared interactors with FAF2 (Figs 1e, 2d and 3c,f), suggesting possible overlapping functions, and also interacted with TBC1D15 and TBC1D17, which were recently reported to function in mitophagy 30 , a process that requires VCP (ref. 31 ).
We performed reciprocal interaction experiments to validate the network. AP-MS experiments using 7 HCIPs as baits identified the corresponding endogenous UBXD adaptor in 6 of 7 baits (Fig. 4a) . We carried out transient-transfection and immunoprecipitation of 19 HCIPs, and validated 16 ( Fig. 4b-o) . These results are consistent with previous studies indicating that ∼70% of HCIPs identified using CompPASS can be validated by reciprocal approaches 12, 13 . Thus, our study suggests that the VCP-UBXD network is linked to numerous biological pathways, and that certain UBXD proteins may function in concert by associating within the same VCP hexamer.
UBXN10 interacts with the IFT-B trafficking complex
UBXN10 is a previously unstudied 'UBX-domain only' adaptor (Fig. 1a) . Proteomic analysis of N-and C-terminally tagged UBXN10 identified 8 members of IFT-B as HCIPs, and 8 members that were below the CompPASS threshold (Figs 2d, 3a and 5a). We also identified a PP4-SMEK phosphatase complex, vesicle-sorting proteins (UNC13 A, B and WDR45L) and UFD1L-NPLOC4. We did not detect any IFT-A subunits, indicating that the interaction is specific to IFT-B (Fig. 3a and Supplementary Table 2 ). Reciprocal AP-MS with 3 HCIPs (IFT88, IFT74 and TTC26) identified VCP, UBXN10 and UFD1L-NPLOC4 (Figs 4a and 5a) , and we validated UBXN10 interaction with IFT81 and WDR45L by co-immunoprecipitation (Fig. 4m,n) . No IFT-B subunits were detected in other UBXD AP-MS experiments (Supplementary Table 1 ), indicating specificity for UBXN10.
To validate the UBXN10-IFT-B interaction, we co-translated 15 MYC-tagged IFT-B subunits with HA-UBXN10 in an in vitro HeLa extract translation system, and tested interactions by coimmunoprecipitation ( Supplementary Fig. 4a ). In this system, extractderived IFT-B subunits assemble with the translated subunit as determined by AP-MS and co-immunoprecipitation ( Supplementary  Fig. 4b-d) . We found that 14 of 15 IFT-B subunits associated with HA-UBXN10 ( Supplementary Fig. 4a ). UBXN10 also associated with UNC13A in this assay (Supplementary Fig. 4a ).
To identify direct binding partners for UBXN10, we translated 15 radiolabelled IFT-B subunits in rabbit reticulocyte lysates, and performed GST pulldowns with Escherichia coli-purified GST-VCP or GST-UBXN10. UBXN10 associated most efficiently with CLUAP1 ( Fig. 5b and Supplementary Fig. 4e ). Weaker interactions with IFT46, 52 and 57 were also detected, but these subunits also bound GST alone at low levels, suggesting a nonspecific interaction ( Supplementary  Fig. 4e ). We did not observe a direct interaction between IFT-B and GST-VCP above that observed with GST alone (Fig. 5b and Supplementary Fig. 4e ). However, addition of HA-UBXN10 enabled the association of CLUAP1 with VCP (Fig. 5c) . Thus, UBXN10 is likely to facilitate recruitment of VCP to IFT-B through CLUAP1.
UBXN10 localizes to cilia in a VCP-dependent manner
Given the association of UBXN10 with IFT-B and the finding that UBXN10 messenger RNA is enriched in cilia-rich tissues 32 , we examined whether UBXN10 localized to the primary cilium. We stably expressed GFP-UBXN10 in hTERT-RPE1, IMCD or LLC-PK1 cells and observed localization within cilia either along the length of the cilium, as discrete puncta within the cilium, or at the ciliary tip as reported for IFT-B subunit IFT88 (Fig. 6a,c and Supplementary Fig. 5a ). Live cell imaging in LLC-PK1 cells demonstrated GFP-UBXN10 trafficking in a bi-directional manner within cilia at rates similar to IFT88 (Fig. 6b and Supplementary Video 1). Furthermore, UBXN10-mCHERRY and EYFP-IFT-B co-trafficked in the same complex, as determined by total internal reflection fluorescence (TIRF) microscopy, strongly suggesting that UBXN10 migrates within the cilium with IFT-B ( Fig. 6c and Supplementary Video 2). We were unable to visualize VCP or UFD1L-NPLOC4 within cilia owing to their high abundance in the cytoplasm ( Supplementary Fig. 5b ). However, VCP has been identified in previous proteomic studies of purified cilia 19, 33 . We examined whether UBXN10 interaction with VCP is required for its ciliary localization. Structural modelling of UBXN10, based on a FAF1-VCP complex 34 , identified a Met-Glu-Val-Pro-Arg (MEVPR) motif as a possible UBXN10-VCP interaction interface ( Fig. 6d and Supplementary Fig. 5c ). Mutation of each residue or deletion of the loop (∆loop) reduced binding to VCP in vivo (Fig. 6e ) and decreased localization of GFP-UBXN10 to cilia, despite equal levels of expression (Fig. 6f,g ). These data indicate that UBXN10 requires VCP interaction to localize within cilia.
VCP-UBXN10 is required for ciliogenesis
Loss of IFT-B subunits leads to the loss or shortening of cilia whereas loss of IFT-A results in malformed cilia that accumulate IFT proteins 35, 36 . Therefore, we examined the involvement of VCP and UBXN10 in cilia formation and maintenance. Depletion of either VCP or UBXN10 in hTERT-RPE1 cells with multiple short interfering RNAs (siRNAs) resulted in a reduction in the number of cilia (ascertained by acetylated tubulin staining; Fig. 7a ). Similar results were observed in LLC-PK1 and hTERT-RPE1 cells expressing GFP-UBXN10 ( Supplementary Fig. 6a,b) . Cell cycle analysis following depletion of VCP or UBXN10 did not identify any overt delay in G 0 /G 1 accumulation (Fig. 7b) , indicating that the phenotypes observed are not a result of secondary cell cycle effects previously observed following VCP depletion. Co-depletion of UFD1L-NPLOC4 by siRNA led to a 15-18% reduction in ciliogenesis (Fig. 7c) . To definitively implicate UBXN10 in ciliogenesis, we used CRISPRCas9 to disrupt the UBXN10 gene in hTERT-RPE1 cells and observed a significant decrease in the number of cilia ( Fig. 7d and Supplementary Fig. 6c ). This defect was rescued by expression of GFP-UBXN10, which correctly localized to the cilium ( Fig. 7d and Supplementary Fig. 6c ). UBXN4 (32) NPLOC4 (12) UFD1L (1) VCP (32) Bait ( (15) UBXN10 (2) NPLOC4 (29) UFD1L (5) VCP (44) IFT88 (2) UBXN10 (1) VCP (17) UBE4A (297) Sub-threshold interactor in FLAG AP-MS UBXN1  UBXN2  FAF1  FAF1  UBXN7  UBXN7  UBXN8  FAF1  UBXN7  FAF2  FAF1  NSFL1C  UBXN8  UBXN2B  FAF2  UBXN1  UBXN10  UBXN10 We also considered the possibility that VCP-UBXN10 was required for the maintenance of pre-formed cilia. As this scenario could not be addressed through prolonged siRNA depletion or deletion studies, we acutely inhibited VCP activity in cells using specific small-molecule inhibitors 37, 38 . hTERT-RPE1 or LLC-PK1 cells were acutely treated with dimethylsulphoxide (DMSO), the ATPcompetitive inhibitor DBeQ, or the allosteric inhibitors NMS-862 and NMS-873 ( Supplementary Fig. 6d ) and the percentage of ciliated TRAF3IP1   IFT81  IFT88  IFT27  IFT46  IFT52  IFT74  IFT80  IFT57  IFT25  CLUAP1/IFT38   RABL5  TTC30A/IFT70  TTC30B/IFT70  TTC26/IFT56   UNC13A   Coomassie  Autoradiograph   TRAF3IP1   IFT81  IFT88  IFT27  IFT46  IFT52  IFT74  IFT80  IFT57  IFT25  RABL5  UNC13A GST-UBXN10 35 S-labelled IFT-B subunits were translated in rabbit reticulocyte lysates and incubated with GST alone or GST-UBXN10 or GST-VCP purified from E. coli. GST pulldowns were resolved by SDS-PAGE, stained with Coomassie and subjected to autoradiography. * :
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cells was determined. Within 1 h of treatment, loss of cilia could be discerned in both cell types (Fig. 7e,f) . At time points longer than 6 hours it was difficult to find cilia for quantification (Fig. 7e,f) . These results demonstrate a requirement of VCP and UBXN10 in the formation and maintenance of cilia.
The stability and activity of IFT-B is dependent on VCP catalytic activity IFT complexes move with well-defined velocities in a cell-typedependent manner. To test whether VCP function is required for IFT-B trafficking, we combined small-molecule VCP inhibitors with timelapse imaging of EYFP-IFT88 and CSAP-Cherry (a centriolar marker used for ciliary orientation) in IMCD cells. Treatment of cells with VCP inhibitors for 4-6 h led to a marked reduction in the length and number of cilia ( Fig. 8a and Supplementary Fig. 7b ). Therefore, ciliated cells were treated acutely with a high concentration of inhibitors to achieve physiologically relevant levels in a rapid time frame (<5 min) and cells were immediately imaged to measure IFT velocity ( Supplementary Fig. 6d ). Acute inhibition caused a significant increase in anterograde and retrograde velocities of EYFP-IFT88 ( Fig. 8b and Supplementary Fig. 7a ). These results are consistent with studies in Chlamydomonas suggesting that disassembly of cilia increases IFT-B velocities possibly owing to the lack of cargo on IFT-B (ref. 39) . At longer times with lower concentrations of DBeQ, the anterograde and retrograde velocities were moderately elevated but not to the extent seen with acute treatment. However, under these conditions, there was also a discernible loss of cilia (Fig. 8a,b and Supplementary Fig. 7a ). We examined whether VCP inhibition impacted UBXN10 trafficking within cilia. TIRF microscopy in IMCD EYFP-IFT88/UBXN10-mCHERRY cells acutely treated with NMS-873 demonstrated a decrease in the number of cilia with UBXN10 trafficking compared with control cells, suggesting that UBXN10 may be uncoupled from IFT-B ( Fig. 8c and Supplementary Fig. 7c ). We also examined whether VCP inhibition altered IFT-A and BBSsome trafficking. We acutely treated IMCD GFP-IFT43 (ref. 40 ) cells with NMS-873 and observed a ∼20% decrease in both anterograde and retrograde velocities of IFT-A (Fig. 8d) . Furthermore, the BBSome subunit BBS5 was depleted from cilia over time in response to VCP inhibition (Fig. 8e,f) . These studies suggest that VCP inhibition may alter the steady-state rates of protein transport within cilia. Assembly and regulation of IFT complexes in vivo is poorly understood. We examined whether VCP inhibition affected the composition of IFT-B complexes. hTERT-RPE1 cells were treated with either DMSO or NMS-873 and lysates were fractionated by gel filtration. Immunoblotting for IFT-B subunits revealed multiple complexes; IFT81 and IFT57 are in two complexes with relative molecular masses (M r ) of between 1,000K-2,000K and 150K. (Fig. 8g and Supplementary Fig. 7d ). In contrast, heterodimeric IFT25 and IFT27 (ref. 41 ) were abundant at M r 66K but were also detected in the M r 1,000K-2,000K complex. VCP inhibition resulted in a reduction of IFT81, IFT25 and IFT27 in the M r 1,000K-2,000K size fractions and an increase in smaller-molecular-weight fractions (Fig. 8g) . Recent studies suggest that IFT25 and 27 exist in two pools, one that associates with the IFT-B complex and a heterodimeric form that regulates access of the BBSome to cilia 42, 43 , which is recapitulated by our gel filtration results. CLUAP1 was present in a M r 1,000K-2,000K complex and a M r 150k complex (also occupied by UBXN10), and VCP inhibition resulted in a reduction in the M r 1,000K-2,000K form of CLUAP1 and the M r 150K form of UBXN10 ( Fig. 8g and Supplementary  Fig. 7d ). We noted that NMS-873 treatment resulted in a decrease in UBXN10 protein levels ( Supplementary Fig. 7d) ; therefore, we examined whether VCP inhibition affected UBXD adaptor levels in cells. Treatment of LLC-PK1 cells with NMS-873 led to a reduction in UBXN10 as well as UBXN7 and FAF2 at 4-6 h post inhibitor treatment (Supplementary Fig. 7f ). However, we observed a rapid loss of ciliary GFP-UBXN10 within 1 h of inhibitor treatment (when protein levels are unaltered relative to control; Supplementary Fig. 7g ). This suggests that VCP inhibition results in the loss of UBXN10 from cilia and that the decline in the adaptor levels may be a secondary effect of prolonged inhibition. At present, we cannot determine whether this effect is due to defects in entry or exit of UBXN10 from cilia. Taken together, these results suggest that VCP inhibition results in selective loss of a subset of proteins from the IFT-B complex.
Loss of UBXN10 in zebrafish results in loss of left-right asymmetry
In zebrafish, defects in ciliary function can be discerned by defects in left-right asymmetry 44 ( Fig. 8h) . To examine the involvement of UBXN10 in cilia-related functions in vivo, we depleted UBXN10 in one-cell zebrafish embryos using morpholinos (MO) and determined heart tube position by in situ hybridization. In control embryos, the heart tube was positioned on the left of the body axis as expected. In contrast, 21% of the Ubxn10 MO embryos exhibited abnormal heart positioning to the midline or to the right (Fig. 8h,i) . Co-injection of human UBXN10 mRNA partially rescued the defect (9%; Fig. 8i ). We observed no significant defect in cardiac positioning using a Ubxn7 MO, indicating specificity for Ubxn10 (Fig. 8i) . These studies support our hypothesis that the VCP-UBXN10 complex has conserved roles in ciliogenesis.
DISCUSSION
This work provides a comprehensive analysis of the VCP-UBXD protein interaction network, identifying over 195 HCIPs, and greatly expands the potential breadth of cellular VCP function by: identifying stable interacting partners for UBXDs with no known function; implicating an adaptor and associated complexes in a known VCP pathway, thereby informing further mechanistic studies; and identifying candidate targets for certain well-studied VCP adaptors. Further work is required to elucidate functional roles for modules identified here.
Although a role for ubiquitin-dependent signalling has long been proposed in cilia-related processes 45, 46 , only recently have E3s and candidate substrates been identified [47] [48] [49] [50] . Our identification of a role for VCP-UBXN10 in cilia formation and maintenance at the cellular and organismal level was unexpected but suggests a role for the segregase activity of VCP in either trafficking of IFT-B itself in cilia or in trafficking of IFT-B cargo. As UBXN10 has no known ubiquitin interaction domains, further studies are necessary to understand the role, if any, of ubiquitin in VCP-UBXN10 function within cilia.
We find that UBXN10 recruits VCP to IFT-B through direct interaction with CLUAP1 and that UBXN10 traffics within cilia along with IFT-B in a bi-directional manner. Although previous proteomic A   IFT172  IFT88  IFT81  IFT80  IFT74  IFT57  IFT52  IFT46  IFT25  IFT27  IFT20   Kinesin   Anterograde IFT-B  CLUAP1  TTC30 A  TTC30B  TTC26   B   IFT144  IFT140  IFT139  IFT122 studies detect VCP in purified cilia 26, 41 , we have been unable to directly visualize VCP within cilia. However, because an interaction between VCP and UBXN10 is required for UBXN10 trafficking to the cilia, we favour the possibility that the VCP-UBXN10 complex traffics within cilia. Further studies are required to test whether VCP enters cilia and whether this requires UBXN10. VCP-UBXN10 depletion or pharmacological inhibition of VCP causes the shortening and eventual loss of cilia and our biochemical studies suggest that this may be due in part to defects in the assembly of IFT25-IFT27 (and perhaps other subunits) within IFT-B. Furthermore, acute treatment of ciliated cells with VCP inhibitors led to increased anterograde and retrograde IFT-B velocities, whereas IFT-A velocities were decreased, indicating a mis-coordination of IFT particle trafficking. We also observe loss of BBS5 in cilia following VCP inhibition. In Caenorhabditis elegans the BBSome is thought to link IFT-A and B complexes within cilia 24 , as genetic deletion of BBSome subunits results in loss of coordinated IFT-A and B trafficking.
Our results suggest that interfering with VCP activity leads to the acute loss of UBXN10 from primary cilia. Subsequently, we detect the disruption of IFT complexes biochemically. We speculate that loss of specific subunits from IFT-B may disable critical interactions with IFT-A, the BBSome complex, cargo and/or motors, leading to cilia shortening and eventual collapse (Fig. 8j) . Whether this regulation of IFT-B occurs within cilia or in the cell body is unclear at present and will be the focus of future studies. Our proteomic study identifies biologically relevant functions for VCP adaptors and provides a rich resource for the further exploration of VCP function in numerous cellular processes.
METHODS
Methods and any associated references are available in the online version of the paper. Cell lines stably expressing EYFP-IFT88 were generated using a blasticidinresistant retroviral vector as previously described 51 . The fluorescently tagged centriole and spindle-associated protein 52 (CSAP) was used as a ciliary orientation marker. The mCherry-tagged CSAP was cloned into a hygromycin-resistant retroviral pBABE vector and introduced into IMCD3 and LLC-PK1 as described previously 51 . Xenopus laevis IFT43 was subcloned into blasticidin-resistant pHAGE N-GFP vector. UBXN10 was cloned into lentiviral vectors to be expressed as an N-EGFP or C-mCHERRY tagged protein. Stable cell lines were selected with blasticidin.
All cell lines were cultured in Dulbecco's modified Eagle's medium, supplemented with 10% fetal bovine serum (FBS), GlutaMAX, 100 units ml −1 , penicillin, 0.1 mg ml −1 streptomycin, and 0.1 mM non-essential amino acids. Cells were maintained in a humidified, 5.0% CO 2 atmosphere at 37 • C. hTERT-RPE1, IMCD3 (clone m368-2) and LLC-PK1 (clone p368-7) cells stably expressing EYFP-IFT88 and mCherry-CSAP were transferred from a culture flask after detachment using trypsin-EGTA into 18-mm-diameter glass coverslips (No. 1.5, Electron Microscopy Sciences). The cells were grown to high confluency to promote the highest frequency of ciliation.
Generation of CRISPR cell lines.
The CRISPR-Cas9 gene editing system was used to generate UBXN10 knockout cell lines in hTERT-RPE1 cells. The guide sequence 5 -ATAAGGCCCAAGTCCGCCAA-3 was cloned into the pX330 vector carrying the hSpCas9 and transiently transfected into hTERT-RPE1 cells along with a pHAGE-HA/FLAG-GFP carrying a blasticidin-resistance cassette using Lipofectamine 3000 (Invitrogen). Thirty-six hours post-transfection the cells were pulsed briefly with 5 µg ml −1 blasticidin for a further 24-36 h. The surviving cells were allowed to recover in drug-free media for 24 h and then serially diluted into 96-well plates for clonal selection. CRISPR-targeted clones were expanded and the UBXN10 locus was PCR amplified and Sanger sequenced. We identified a frame-shift at Pro 12 that introduces a premature stop codon at the endogenous UBXN10 locus.
Interaction proteomics and mass spectrometry analysis. Interaction proteomics was performed as described previously 12, 13 . Briefly, 293T or HeLa cells were transduced with a lentiviral vector expressing either N-or C-HA/FLAG-tagged VCP or its UBX-domain-containing adaptors and stable cell lines were selected with puromycin. HEK-293T cells from 8 × 15 cm dishes were collected for duplicate anti-FLAG AP-MS studies. The biological duplicates were processed in parallel as follows. Cells were lysed in 3 ml of 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.5% Nonidet P40, 1 mM dithiothreitol and protease and phosphatase inhibitors. Clarified lysates were filtered through 0.45 µm spin filters (Millipore Ultrafree-CL) and immunoprecipitated with 60 µl anti-FLAG magnetic beads per replicate (Sigma). Complexes were washed 4× with lysis buffer, and 3× with PBS and eluted with FLAG peptide at room temperature. Elutions were reductively carboxymethylated, and TCA-precipitated. TCA-precipitated proteins were trypsinized, purified with Empore C18 extraction media (3 M), and analysed using LC-MS/MS with a LTQ-Velos linear ion trap mass spectrometer (Thermo) with an 18 cm 3 125 µm (ID) C18 column and a 50 min 8-26% acetonitrile gradient. Complexes were analysed twice by LC-MS to generate technical duplicates. AP-MS experiments using HA resin (Sigma) were also performed on a single IP but with technical duplicates. Spectra were searched with Sequest against a target-decoy human tryptic UNIPROT-based peptide database, and these results were loaded into CompPASS (refs 12,13) , to identify high-confidence candidate interacting proteins (HCIPs). Individual experiments were analysed using a stats table derived from analogous AP-MS data for 41 (for FLAG AP-MS) or 168 (for HA AP-MS) unrelated proteins to determine normalized weighted D scores (NWD score) and Z-scores based on spectral counts.
To identify bait-associated proteins, proteins were filtered at a 3% false discovery rate for those with a NWD-score ≥ 0.98, Z-score ≥ 4, and average assembled peptide spectral matches (APSMs) ≥ 2 in both biological duplicates (for FLAG AP-MS). An identical cutoff was used for the single HA AP-MS for each tagged bait. Baits were removed from all HCIP lists before HCIP calculation. To evaluate the statistical significance of each bait-prey interaction, a hypergeometric test was applied comparing the null hypothesis that detection of bait and prey was independent across LC-MS analyses, versus the alternative hypothesis that bait and prey were detected preferentially together (Supplementary Table 4 ). For purposes of this analysis, AP-MS data were separated according to the location of the affinity tag (N versus C terminus) and according to whether HA or FLAG purification was performed. P values were subsequently corrected to account for multiple hypothesis testing using the method of Benjamini and Hochberg 53 . HCIPs designated in this study generally had adjusted P values ≤ 0.05 (Supplementary Table 4 ). The only exceptions were for interactors that associated with VCP itself and for UBXD-UBXD associations. As the very abundant VCP protein (∼1% of the total cellular protein) was ubiquitously detected across FLAG AP-MS analyses, detection-based statistical analyses such as the hypergeometric test described here will be insensitive to associations with its interactors. Some UBXD-UBXD associations similarly fail to meet significance cutoffs in this statistical analysis owing to high frequency of detection across these LC-MS analyses. This list of HCIPs from the anti-FLAG data set was cross-referenced with the interactors in the anti-HA data set and interaction maps were generated using Cytoscape. In situations where known members of an associating complex were identified in the IP but did not pass our cutoffs, these were included in Fig. 3 and Supplementary Fig. 3 . APSMs for the HCIPs identified in the FLAG data sets were bait normalized and plotted in a heatmap form using Multiexperiment Viewer.
Validation studies. A subset of interactors were used to reciprocally validate the interaction with either VCP or the UBXD adaptor. Interactors were cloned into lentiviral vectors containing a N-HA/FLAG tag. Stable cell lines were generated for 7 interactors and analysed by AP-MS as described above. IFT-B stable cell lines were generated in hTERT-RPE1 cells. Nineteen interactors were cloned into epitopetagged vectors and transiently transfected with its cognate tagged UBXD into 293T cells. At 48 h post-transfection, cells were lysed and clarified lysates were used to immunoprecipitate the tagged HCIP and immunoblotted for the UBXD protein.
Antibodies, siRNAs and reagents. The rabbit VCP (cat. no. A300-588A, 1:1,000 dilution), rabbit UBXN7 (cat. no. A303-865A, 1:1,000 dilution) and rabbit FAF1 antibody (cat. no. A302-810A, 1:1,000 dilution) were from Bethyl. Rabbit FAF2 (cat. no. S0495, 1:1,000 dilution) was from Epitomics. Rabbit UBXN1 (cat. no. AB10041, 1:1,000 dilution) was from Millipore. Rabbit UBXN10 antibody was from Sigma (cat. no. HPA028564, 1:500 dilution), mouse UFD1L antibody was from BD Biosciences (cat. no. 611642, 1:1,000 dilution), rabbit NPLOC4 (cat. no. HPA021650, 1:1,000 dilution) and mouse acetylated tubulin (cat. no. T7451 clone 6-11B-1, 1:10,000 dilution) antibodies were from Sigma, mouse HA antibody was from Covance (cat. no. MMS-101P, clone 16B12, 1:1,000 dilution), mouse PCNA (cat. no. SC-56, clone PC10, 1:1,000 dilution), mouse MYC (cat. no. SC-40, Clone 9E10, 1:1,000), Tomm20 (cat. no. SC-11415, 1:500 dilution) and rabbit γ-tubulin (cat. no. SC-10732, 1:500 dilution) antibodies were from Santa Cruz. Rabbit pericentrin antibody was from Abcam (cat. no. AB4448, 1:500 dilution). IFT81 (cat. no. 11744-1-AP, 1:1,000 dilution), IFT57 (cat. no. 11083-1-AP, 1:1,000 dilution), IFT25 (cat. no. 15732-1-AP, 1:1,000 dilution), IFT27 (cat. no. 15017-1-AP, 1:1,000 dilution) and BBS5 (cat. no.in storage buffer containing 50% glycerol. GST-VCP was incubated with in vitrotranslated HA-UBXN10 for 1 h on ice.
IFT-B subunits in pT7CFE vectors were translated in rabbit reticulocyte lysate (Promega) in the presence of 5 µCi of 35 S (Perkin Elmer) for 1 h at 30 • C. Fifteen per cent of the reaction was saved as input and the remaining reaction was diluted and incubated with GST-tagged proteins for 2 h at 4 • C. The beads were extensively washed and the samples then resolved by SDS-PAGE. Interactions were visualized by autoradiography. The experiment was performed 2 independent times.
Immunofluorescence and microscopy. HeLa, hTERT-RPE1, IMCD or LLC-PK1 cells were grown on coverslips and fixed with 4% paraformaldehyde at room temperature for 15 min. Cells were washed in PBS, permeabilized in 0.2% Triton X-100 for 5 min, washed again and then blocked in 1% BSA in PBS for 1 h. The coverslips were incubated with the indicated antibodies for 1 h in a humidified chamber, washed and incubated for a further hour with appropriate Alexa-Fluorconjugated secondary antibodies (Invitrogen) for 1 h in the dark. Cells were washed with PBS, nuclei were stained with Hoechst and the cells were mounted on slides. All images were collected with a Yokogawa CSU-X1 spinning-disc confocal on a Nikon Ti-E inverted microscope equipped with a 100× Plan Apo NA 1.4 objective lens. The indicated fluorophores were excited with either a 491 nm, 561 nm or 642 nm laser line using an AOTF-controlled solid-state laser launch. Emission spectra were collected with a quad band-pass polychroic mirror and Chroma emissions filters ET525/50m (488 nm), ET620/60m (561) and ET700/75 (642). Images were acquired with a Hamamatsu ORCA-AG cooled CCD (charge-coupled device) camera controlled with MetaMorph 7 software. Ten to fifteen z-series optical sections were collected with a step size of 0.2 µm using a Prior Proscan focus motor. Z-series were deconvolved using AutoQuant blind deconvolution software, and shown as maximum z-projections. Gamma and brightness were adjusted on displayed images (identically for compared image sets using MetaMorph 7 software). Ciliated cells were counted on the basis of acetylated tubulin staining using pericentrin as an orientation marker. To determine BBS5 localization to cilia, the intensity of BBS5 within cilia (based on the acetylated tubulin staining) was quantified and normalized to the length of each cilium measured in MetaMorph. For immunofluorescence-based quantification studies, fields of cells were chosen on the basis of the Hoechst (nuclei) channel to prevent biased image acquisition. On average 150-350 cells were quantified for each sample in two separate experiments. All experiments were performed at least 2 independent times.
IFT velocity measurements and TIRF. Velocity measurements of IFT88, IFT43 and UBXN10 were performed as described previously 51 . The cells were rinsed with PBS and subjected to the transport measurements by inversion of the monolayer onto a larger size (35 mm) coverslip and mounted on the stage of a Nikon Eclipse Ti inverted microscope equipped with a Nikon Plan Fluor 100× Plan Apo NA 1.4 objective lens and a CoolSnap-HQ (Photometrics). The Nikon FITC and HcRED1 cubes were used to efficiently reflect 488 nm and 575 nm wavelengths correspondingly and pass the emission wavelengths into the CCD camera detection channel. The acquisition settings were kept constant for all samples so that valid comparisons could be made between measurements from different data sets. Acquisition parameters were set within the linear range of the CCD camera detection. The acquired fluorescence image time series were subjected to the kymograph analysis using the ImageJ software package (http://rsbweb.nih.gov/ij). The standard deviations of the recovered mean values were obtained from the analysis of the trajectories of multiple particles.
The ciliary particle transport in cells stably co-expressing EYFP-IFT88 and UBXN10-mCherry was sampled using total internal reflection fluorescence (TIRF) microscopy. Similarly to EPI-fluorescence imaging, coverslips were mounted on the stage of a Nikon Eclipse Ti inverted microscope equipped with a Nikon motorized TIRF illuminator and a Nikon CFI Apo TIRF 100× oil 1.49 NA objective lens. The fluorophores were excited using 491 nm and 561 nm 50 mW solid-state lasers coupled together using a laser merge module with acousto-optic tunable filter (Spectral Applied Research). TIRF image time series were acquired with a Hamamatsu ORCA-D2 CCD camera controlled with MetaMorph 7 software. For particle velocity measurement, one hundred images were continuously (49.44 ms read-out time per frame) collected using an exposure time of 100 ms and 2 × 2 binning. The acquisition parameters were set within the linear range of the CCD camera detection. The acquired fluorescence image time series were subjected to the kymograph analysis of the ImageJ software package (http://rsbweb.nih.gov/ij). The standard deviations of the recovered mean values were obtained from the analysis of the trajectories of multiple particles.
For drug treatments, cells on coverslips were treated with either 50 µM DBeQ or NMS-862 or NMS-873, inverted immediately onto 35 mm coverslips and immediately imaged. These measurements lasted for 5 min. For longer incubations, cells were treated with either 5 µM (NMS-862 or NMS-873) or 10 µM (DBeQ) for 1, 4 or 6 h. These experiments were performed 2 independent times.
Morpholino-based studies in Danio rerio. Zebrafish were maintained according to established IACUC protocols. Wild-type (strain AB) zebrafish embryos were used. Embryos were used from 0-26 h post-fertilization (hpf), at which time the sex of the animal is not known. Zebrafish male and female adults used in matings were <1 year old. Embryos were injected at the 1-cell stage with morpholinos (MOs; GeneTools) designed to block either the ATG start site or an exon-intron splice site of the target gene (Ubxn10 MO, ATG start site, 5 -ACGTGCATCCTTTCTCCAGAGGACA-3 , Ubxn7 MO, splice site 5 -ATGCGTCTCCGAGAGTCGCCATCTT-3 ). MOs were injected at concentrations of 250-330 µM. Hs GST-UBXN10 RNA (50-100 pg) was injected into embryos along with the morpholino for rescue studies. Embryos were fixed in 4% PFA at 26 h hpf for in situ hybridization using published methods (http://zfin.org/ZFIN/Methods/ThisseProtocol.html). Gene expression was visualized using the pan-cardiomyocyte marker cmlc2. Zebrafish embryos from a single clutch were allocated to experimental groups (that is, control and MOinjected groups) at the 1-cell stage before MO injection, at which time they are indistinguishable from one another and the genetic makeup of each embryo is unknown (zebrafish are not isogenic). The number of morphant embryos exhibiting abnormal gene expression (cardiac jogging laterality defects) was compared with control embryos, and statistical significance was determined by Fisher's exact test. These experiments were performed 3 independent times.
Gel filtration analysis. hTERT-RPE1 cells were grown in 15 cm dishes and starved in 0.2% FBS for 48 h. Cells were treated with either DMSO or 5 µM NMS-873 (in DMSO) for 4 h. Cells were collected and lysed in 1 ml of lysis buffer: 50 mM HEPES pH 7.4, 150 mM KCl, 1 mM EGTA, 1 mM MgCl 2 , 10% glycerol, and 0.05% NP-40. Cells were centrifuged for 1 h at 16,000g . Samples were loaded on a Superose 6 size 10/300 GL column (GE Health Sciences) and 0.5 ml fractions were collected. Total protein from each fraction was TCA-precipitated and washed with acetone 3 times. Samples were dried and resuspended in SDS sample buffer. Equal volumes of fractions were resolved by SDS-PAGE and samples were resolved on SDS-PAGE and immunoblotted with the indicated antibodies.
Statistical analyses.
No statistical method was used to predetermine sample size. Sample sizes for all relevant studies were chosen on the basis of previously published studies by our groups. The experiments were not randomized. For immunofluorescence-based quantification studies, fields of cells were chosen on the basis of the Hoechst (nuclei) channel to prevent biased image acquisition. The investigators were not blinded to allocation during experiments and outcome assessment. When gene expression data were gathered from experimental groups following in situ hybridization for cmlc2, the researcher knowingly scored the control group first to determine what normal gene expression looks like.
Data sets and accession codes. The UBXN10 UBX domain was modelled onto the crystal structure of the FAF1 UBX domain in complex with the VCP N terminus (PDB accession code http://www.pdb.org/pdb/search/structidSearch. do?structureId=3QWZ) using Phyre2.0 (http://www.sbg.bio.ic.ac.uk/phyre2/html). All MS data have been deposited on PeptideAtlas and can be accessed at http://www.peptideatlas.org/PASS/PASS00701. In the version of this Resource originally published, the sequence for the UBXN7 morpholino was reported incorrectly in the Methods section as 5ʹ-TTTTGGATTCTCCACCCGAAGCCAT-3ʹ. The correct sequence is 5ʹ-ATGCGTCTCCGAGAGTCGCCATCTT-3ʹ. This has been corrected in all online versions of the Resource.
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Supplementary Figure-1 UBXN6  UBXN4  UBXN10  UBXN2A  UBXN11  UBXN8  UBXN7  FAF2  UBXN1  FAF1  NSFL1C  UFD1L  VCP  NPLOC4  UBXN2B e   UBXN6  UBXN4  UBXN10  UBXN2A  UBXN11  UBXN8  UBXN7  FAF2  UBXN1  FAF1  NSFL1C  UFD1L  VCP  NPLOC4  UBXN2B  ASPSCR1   UBXN6  UBXN4  UBXN10  UBXN2A  UBXN11  UBXN8  UBXN7  FAF2  UBXN1  FAF1  NSFL1C  UFD1L  VCP  NPLOC4  UBXN2B  ASPSCR1  UBXN6  UBXN4  UBXN10  UBXN2A  UBXN11  UBXN8  UBXN7  FAF2  UBXN1  FAF1  NSFL1C  UFD1L  VCP  NPLOC4  UBXN2B TRAF3IP1   IFT81  IFT88  IFT27  IFT46  IFT52  IFT74  IFT80  IFT57  IFT25  CLUAP1  RABL5  TTC30A  TTC30B  TTC26  UNC13A   Coomassie  Autoradiograph   TRAF3IP1   IFT81  IFT88  IFT27  IFT46  IFT52  IFT74  IFT80  IFT57  IFT25  CLUAP1  RABL5  TTC30A  TTC30B  TTC26  UNC13A GST-UBXN10 GST * GST-VCP 15% Input S-rabbit reticulocyte translated protein 35   TRAF3IP1   IFT81  IFT88  IFT27  IFT46  IFT52  IFT74  IFT80  IFT57  IFT25  CLUAP1  RABL5  TTC30A  TTC30B  TTC26 Maxima, centre, minima and quartiles (Q1,2,3) for each sample from left to right : (68, 33, 8, 14, 20, 29) , (38, 16, 6, 9, 12, 19) (29, 13, 3, 7, 12, 17) , (21, 9, 3, 8, 9, 18) . Error bars represent mean ± s.d. Statistical significance calculated using ANOVA, p values compared to DMSO are shown. ** p≤ 0.01.
